Deans' stroke musings: Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, July 20, 2019

Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease

Maybe the full article tells you something but this said absolutely nothing useful.

Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease

Heart Rhythm — Bunch TJ, et al. | July 12, 2019

Researchers examined patients with and without atrial fibrillation (AF) and carotid arterial disease (CD), or a combination of both, to determine the risks of stroke, transient ischemic attack (TIA), and dementia. They also investigated if these risks may be influenced by therapies for each disease. A total of 11,572 patients were included in this analysis. Participants were matched by age, sex, and comorbidities and divided into four equal categories (1: no AF or CD, 2: AF, no CD, 3: CD, no AF, 4: AF and CD). According to the findings, the risk of stroke/TIA and dementia in the general population was augmented by CD and AF, and the coexistence of both diseases was determined to be additive in risk. Ablation of AF was linked to lower risk, the significance of which was greater in those with CD.